Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 8615-8623, September 15, 2007. doi: 10.1158/0008-5472.CAN-07-0232
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopitz, C.
Right arrow Articles by Krüger, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopitz, C.
Right arrow Articles by Krüger, A.

Cell, Tumor, and Stem Cell Biology

Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling

Charlotte Kopitz1, Michael Gerg1, Obul Reddy Bandapalli4, Dilek Ister1, Caroline J. Pennington6, Stephanie Hauser1, Christin Flechsig1, Hans-Willi Krell7, Dalibor Antolovic5, Keith Brew8, Hideaki Nagase9, Manfred Stangl2, Claus W. Hann von Weyhern3, Björn L.D.M. Brücher2, Karsten Brand4, Lisa M. Coussens10, Dylan R. Edwards6 and Achim Krüger1

1 Institut für Experimentelle Onkologie und Therapieforschung, 2 Chirurgische Klinik, and 3 Institut für Allgemeine Pathologie und Pathologische Anatomie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany; 4 Institute of Pathology and 5 Department of Surgery, University Hospital Heidelberg, Heidelberg, Germany; 6 School of Biological Sciences, University of East Anglia, Norwich, Norfolk, United Kingdom; 7 Roche Diagnostics GmbH, Penzberg, Germany; 8 Department of Biomedical Science, Florida Atlantic University, Boca Raton, Florida; 9 The Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, London, United Kingdom; and 10 Department of Pathology and Comprehensive Cancer Center, University of California, San Francisco, California

Requests for reprints: Achim Krüger, Institut für Experimentelle Onkologie und Therapieforschung, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, D-81675 Munich, Germany. Phone: 49-89-4140-4463; Fax: 49-89-4140-6182; E-mail: achim.krueger{at}lrz.tu-muenchen.de.

Balanced expression of proteases and their inhibitors is one prerequisite of tissue homeostasis. Metastatic spread of tumor cells through the organism depends on proteolytic activity and is the death determinant for cancer patients. Paradoxically, increased expression of tissue inhibitor of metalloproteinases-1 (TIMP-1), a natural inhibitor of several endometalloproteinases, including matrix metalloproteinases and a disintegrin and metalloproteinase-10 (ADAM-10), in cancer patients is negatively correlated with their survival, although TIMP-1 itself inhibits invasion of some tumor cells. Here, we show that elevated stromal expression of TIMP-1 promotes liver metastasis in two independent tumor models by inducing the hepatocyte growth factor (HGF) signaling pathway and expression of several metastasis-associated genes, including HGF and HGF-activating proteases, in the liver. We also found in an in vitro assay that suppression of ADAM-10 is in principle able to prevent shedding of cMet, which may be one explanation for the increase of cell-associated HGF receptor cMet in livers with elevated TIMP-1. Similar TIMP-1–associated changes in gene expression were detected in livers of patients with metastatic colorectal cancer. The newly identified role of TIMP-1 to create a prometastatic niche may also explain the TIMP-1 paradoxon. [Cancer Res 2007;67(18):8615–23]




This article has been cited by other articles:


Home page
Sci SignalHome page
W. G. Stetler-Stevenson
Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
Sci. Signal., July 8, 2008; 1(27): re6 - re6.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bendrik, J. Robertson, J. Gauldie, and C. Dabrosin
Gene Transfer of Matrix Metalloproteinase-9 Induces Tumor Regression of Breast Cancer In vivo
Cancer Res., May 1, 2008; 68(9): 3405 - 3412.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. Wu, J. Liu, M. P. Waalkes, M.-L. Cheng, L. Li, C.-X. Li, and Q. Yang
High Dietary Fat Exacerbates Arsenic-Induced Liver Fibrosis in Mice
Experimental Biology and Medicine, March 1, 2008; 233(3): 377 - 384.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden
Migratory neighbors and distant invaders: tumor-associated niche cells
Genes & Dev., March 1, 2008; 22(5): 559 - 574.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.